Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)

Ellie Chabi, MD, therapeutic area head for Glaucoma & Neuroprotection, lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, shares insight on the company's role in the panel discussion focusing on new developments and discoveries in the glaucoma space during the 2020 Glaucoma 360 annual meeting in San Francisco, California.

See more Glaucoma 360 coverage here 


Related Videos
ViaLase seeks to disrupt glaucoma treatment paradigm with new femtosecond laser treatment
Contralateral eye study investigates iStent vs Hydrus stent for glaucoma
Robot-assisted micro interventional glaucoma surgery reduces surgeon's tremors
Related Content
© 2023 MJH Life Sciences

All rights reserved.